Literature DB >> 29157403

Spinal Cord MRI in Multiple Sclerosis.

Alexandra Muccilli1, Estelle Seyman2, Jiwon Oh3.   

Abstract

Spinal cord (SC) MRI in multiple sclerosis (MS) has significant usefulness in clinical and investigational settings. Conventional MRI of the SC is used in clinical practice, because it has both diagnostic and prognostic value. A number of advanced, quantitative SC MRI measures that assess the structural and functional integrity of the SC have been evaluated in investigational settings. These techniques have collectively demonstrated usefulness in providing insight into microstructural and functional changes relevant to disability in MS. With further development, these techniques may be useful in clinical trial settings as biomarkers of neurodegeneration and protection, and in day-to-day clinical practice.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical usefulness; MRI; Multiple sclerosis; Prediction; Quantitative techniques; Spinal cord

Mesh:

Year:  2018        PMID: 29157403     DOI: 10.1016/j.ncl.2017.08.009

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  6 in total

1.  The impairment of the functional system and fatigue at the onset of the disease predict reaching disability milestones in relapsing-remitting multiple sclerosis differently in female and male patients.

Authors:  Alina Ivaniuk; Yuliia Solodovnikova; Tetiana Marusich; Anatoliy Son
Journal:  Acta Neurol Belg       Date:  2020-09-30       Impact factor: 2.396

2.  Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression.

Authors:  Constantina A Treaba; Allegra Conti; Eric C Klawiter; Valeria T Barletta; Elena Herranz; Ambica Mehndiratta; Andrew W Russo; Jacob A Sloane; Revere P Kinkel; Nicola Toschi; Caterina Mainero
Journal:  Brain Commun       Date:  2021-06-24

Review 3.  A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.

Authors:  Jacqueline M Solomon; Friedemann Paul; Claudia Chien; Jiwon Oh; Dalia L Rotstein
Journal:  Ther Adv Neurol Disord       Date:  2021-05-09       Impact factor: 6.570

4.  Application of Dynamic Enhanced Magnetic Resonance Imaging in the Diagnosis of Hematological Malignancies.

Authors:  Yanping Shao; Xueping Bao; Caifang Song; Danping Cui
Journal:  J Healthc Eng       Date:  2021-12-23       Impact factor: 2.682

Review 5.  Clinical, Radiological and Pathological Characteristics Between Cerebral Small Vessel Disease and Multiple Sclerosis: A Review.

Authors:  Bijia Wang; Xuegang Li; Haoyi Li; Li Xiao; Zhenhua Zhou; Kangning Chen; Li Gui; Xianhua Hou; Rong Fan; Kang Chen; Wenjing Wu; Haitao Li; Xiaofei Hu
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

6.  Reply to "Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS".

Authors:  Antje Bischof; Nico Papinutto; Anisha Keshavan; Anand Rajesh; Gina Kirkish; Xinheng Zhang; Jacob M Mallott; Carlo Asteggiano; Simone Sacco; Tristan J Gundel; Chao Zhao; William A Stern; Eduardo Caverzasi; Yifan Zhou; Refujia Gomez; Nicholas R Ragan; Adam Santaniello; Alyssa H Zhu; Jeremy Juwono; Carolyn J Bevan; Riley M Bove; Elizabeth Crabtree-Hartman; Jeffrey M Gelfand; Douglas S Goodin; Jennifer S Graves; Ari J Green; Jorge R Oksenberg; Emmanuelle Waubant; Michael R Wilson; Scott S Zamvil; Bruce A Cree; Stephen L Hauser; Roland G Henry
Journal:  Ann Neurol       Date:  2022-03-26       Impact factor: 11.274

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.